CEBINA publishes data demonstrating the anti-histamine azela

CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of research results demonstrating that the commonly used

Related Keywords

Austria , Vienna , Wien , Sophie Zettl , Eszter Nagy , Robert Konrat , Healthcare Pharmaceuticals Industry , University Of Vienna , Central European Biotech Incubator , Professor Dr Robert Konrat , Anti Histamine Azelastine , Computational Drug Repurposing , Inhibits Infection , Major Variants , Cell Cultures , Reconstituted Human Tissue , Internet News Presswire , Editorial Guidelines , Cebina , Publishes , Data , Demonstrating , The , Anti Histamine , Azelastine , Inhibits , Infection , Baby , Major , Variants , Of , Sars Cov 2 ,